1. Academic Validation
  2. Aclidinium inhibits proliferation and metastasis of ovarian cancer SKOV3 cells via downregulating PI3K/AKT/mTOR signaling pathway

Aclidinium inhibits proliferation and metastasis of ovarian cancer SKOV3 cells via downregulating PI3K/AKT/mTOR signaling pathway

  • Oncol Lett. 2018 Nov;16(5):6417-6422. doi: 10.3892/ol.2018.9460.
Juan Qiao 1 Wei-Jing Wang 2 Yuan Zhang 3
Affiliations

Affiliations

  • 1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.
  • 2 Gynecology Department Five of The Harbin Red Cross Center Hospital, Harbin, Heilongjiang 150076, P.R. China.
  • 3 Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570203, P.R. China.
Abstract

Aclidinium, a muscarinic antagonist, is generally used to treat the respiratory system diseases whereas it is not clear whether aclidinium has therapeutic effect in ovarian Cancer (OC). The aim of this study was to investigate the impact of aclidinium on OC and its potential mechanism. CCK-8 was employed to test the potential effect of aclidinium on SKOV3 cell proliferation. Transwell migration and invasion assay was performed to assess the influence of aclidinium on SKOV3 cell metastasis and invasion. Furthermore, flow cytometry apoptotic analysis was used to evaluate the effect of aclidinium on cell Apoptosis. Finally, western blotting was applied to determine the changes of key proteins in Apoptosis and PI3K/Akt/mTOR signaling pathway induced by aclidinium. The study showed that aclidinium had antiproliferative activity on SKOV3 cells. Simultaneously, aclidinium could significantly inhibit the number of migrated and invaded SKOV3 cells and markedly increased the SKOV3 cell Apoptosis rate. Mechanistically, the expression of PI3K/Akt/mTOR signaling pathway related proteins were significantly inhibited in aclidinium treated SKOV3 cells. Our findings proposed a clue for further OC studies in preclinical and clinical treatment and aclidinium may be useful for the treatment of OC in the future.

Keywords

PI3K/AKT/mTOR signaling pathway; aclidinium; ovarian cancer; proliferation.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》